Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Eastham
    Eastham
  5. Jarnagin
    Jarnagin
  6. Reuter
    Reuter
  7. D'Angelica
    D'Angelica
  8. Kingham
    Kingham
  9. Ladanyi
    Ladanyi
  10. Scher
    Scher

Groups

  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)
  7. Epidemiology and Biostatistics (685)
  8. Sloan Kettering Institute Faculty (612)
  9. Department of Pathology and Laboratory Medicine (586)
  10. GSK Faculty (582)
Search Within
Formats
  1. Journal Article (3901)
  2. Meeting Abstract (1049)
  3. Editorial (165)
  4. Review (132)
  5. Correspondence (113)
  6. Guidelines (79)
  7. Research Letter (29)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (223)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (161)
  6. William Jarnagin (157)

More People

Years
  1. 2025 (96)
  2. 2024 (256)
  3. 2023 (234)
  4. 2022 (264)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (762)
  2. European Urology (570)
  3. Lancet Oncology (394)
  4. Urology (388)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (272)

More Publications

Results (5503)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rucaparib for the treatment of metastatic castration-resistant prostate cancer associated with a DNA damage repair gene alteration: Final results from the phase 2 TRITON2 study
    Journal Article

    Abida, W.; Campbell, D.; Patnaik, A.; Bryce, A. H.; Shapiro, J.; Bambury, R. M.; Zhang, J.; Burke, J. M.; Castellano, D.; Font, A.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • PARP inhibitors for prostate cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) blues
    Editorial

    Beije, N.; Abida, W.; Antonarakis, E. S.; Castro, E.; de Wit, R.; Fizazi, K.; Gillessen, S.; Hussain, M.; Mateo, J.; Morris, M. J.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): A single-arm, multicentre, phase 2 trial
    Journal Article

    Albiges, L.; Gurney, H.; Atduev, V.; Suarez, C.; Climent, M. A.; Pook, D.; Tomczak, P.; Barthelemy, P.; Lee, J. L.; Stus, V.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: Challenges and recommended priorities
    Review

    Kim, M. M.; Mehta, M. P.; Smart, D. K.; Steeg, P. S.; Hong, J. A.; Espey, M. G.; Prasanna, P. G.; Crandon, L.; Hodgdon, C.; Kozak, N.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): An international, single-arm, phase 2 study
    Journal Article

    Pant, S.; Schuler, M.; Iyer, G.; Witt, O.; Doi, T.; Qin, S.; Tabernero, J.; Reardon, D. A.; Massard, C.; Minchom, A.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): Phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
    Journal Article

    Rubinstein, P. G.; Moore, P. C.; Bimali, M.; Lee, J. Y.; Rudek, M. A.; Chadburn, A.; Ratner, L.; Henry, D. H.; Cesarman, E.; DeMarco, C. E.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • The acknowledgment of death
    Correspondence

    Dee, E. C.
    Lancet (2023)

    Fulltext@MSK | Save
  • Yttrium-90 activity quantification in PET/CT–guided biopsy specimens from colorectal hepatic metastases immediately after transarterial radioembolization using micro–CT and autoradiography
    Journal Article

    Naydenov, N.; Teplov, A.; Zirakchian, M. Z.; Ruan, S.; Chu, B. P.; Serencsits, B.; Iraca, M.; Talarico, O.; Miller, B.; Kunin, H.; more...
    Journal of Vascular and Interventional Radiology (2023)

    Fulltext@MSK | Save
  • GRADE reporting in systematic reviews published in the urological literature (2009-2021)
    Journal Article

    Norling, B.; Jung, J. H.; Hwang, E. C.; Han, M. A.; Khaleel, S.; Schünemann, H. J.; Dahm, P.
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Health-related quality of life after robotic-assisted vs open radical cystectomy: Analysis of a randomized trial. Reply
    Correspondence

    Clements, M. B.; Beech, B. B.; Atkinson, T. M.; Dalbagni, G. M.; Li, Y.; Vickers, A. J.; Herr, H. W.; Donat, S. M.; Sjoberg, D. D.; Tin, A. L.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save